Author: editor

Rasna the Drink of India “Ho Gaya Hai Bilkul Free”

Rasna ties up with Paytm to give 100% cashback on their multiple packs

  • Offers cashback to customers by scanning Paytm’s QR code on Rasna’s 32 glass packs, 10 glass packs and Rs. 5 packs through the Paytm app
  • Launches ad campaign in various platforms such as TV, social media, print etc. and also features Rasna’s new ambassador, Chhota Bheem

Rasna, the world’s largest selling soft drink concentrate and an icon of Make in India has launched a new campaign offering 100% cashback to its customers. Rasna, the leader in the soft drink segment tied up India’s largest payment platform, Paytm. This campaign is rolled out in various platforms such as TV, social media, print etc and also features Rasna’s new ambassador, Chhota Bheem. Watch Rasna TVC.

Rasna Orange

The Paytm cashback offer is on Rasna 32 glass packs, 10 glass packs and Rs. 5 pack. The Rasna TVC with Chhota Bheem have been released over multiple channels where he interacts with a mother for an achievement party while announcing the cashback offer and says the iconic line ‘I Love you Rasna’ with the Rasna girl. Customers can avail this cash back offer by purchasing the pack and scanning the QR Code on the pack via the Paytm app. Apart from Cashbacks, multiple other offers such as offers on movie ticket bookings, flight bookings, online shopping are also available.

Rasna products are known to be healthy and fruity containing fruit extracts, 11 vitamins, minerals, and glucose. They are available in multiple flavours like – Nagpur Orange, Alphonso Mango, American Pineapple, Shahi Gulab, Kool Khus, Kesar Elaichi, Masala Nimbu, Shikanji Limbu Pani, Litchi, and Kala Khatta.
Commenting on the launch Mr. Piruz Khambatta, Chairman – Rasna Group has stated, “We take pride in associating with India’s largest payment platform Paytm which will help us reach their huge network of millions of Paytm users. Both the brands are proudly made in India and have been a pioneer in their respective fields. In this scorching heat, Rasna is a necessity, so a 100% Cashback is a boon. ‘Rasna bilkul free‘ is a blessing for the middle-class and lower segments of the society who are ideally Rasna’s target audience in the small cities of the country.”

Commenting on the launch Narendra Yadav – Vice President, Paytm said, “Rasna is a much loved soft drink across the country and we are glad to be associated with them to give consumers a little bit of respite during the summers. As a brand that puts consumers first, Paytm pioneered the QR code revolution in India and enables users with convenient digital payments through Paytm Wallet, Paytm UPI, Paytm Postpaid (Buy Now, Pay Later), netbanking, debit and credit cards and more.”

View article…

(Disclaimer: The above press release comes to you under an arrangement with NewsVoir India and this publication takes no editorial responsibility for the same)

SBI General expands its digital footprint with InsureMO platform, enabling daily issuance of over half a million bite-sized Insurance policies in India

MUMBAI, India, June 2, 2022 /PRNewswire/ — In line with SBI General’s vision of digitisation across customer journeys and processes, the Company has adopted a dynamic digital platform offered by InsureMO®, thereby making the digital buying journeys seamless and enabling lesser dependencies on Core Policy Administration Systems.

With InsureMO, SBI General was able to onboard Digital channels for its existing retail products at a faster pace and lower costs.

InsureMO platform is inherently built to handle large variations, velocity and volumes needed to support an extensive product portfolio with its microservices based architecture. The wide variety of APIs and the configurability of the platform ensures faster time-to-market. Moderate CapEx and OpEx make such digital propositions more viable, sustainable and encourage incremental innovations across products.

Anand Pejawar, Dy. Managing Director, SBI General said, “We at SBI General, have always been at the forefront of digitisation. We are consistently strengthening our digital distribution networks / channels by working on systems and processes that support our extensive network of distributors, including Bank branches, coupled with an equally large product portfolio which makes it cost effective and sustainable. We meticulously choose and work with our tech partners to ensure that we provide our distributors and end use customers with the most effective, innovative latest state of art technology solutions through their preferred modes and platforms. Our partnership with InsureMO is one of such initiatives in this direction”.

“InsureMO is glad to be one of the pillars for SBI General in its growth trajectory focusing on digitalization. With our capabilities and efficiencies, we are also able to contribute with innovative approaches that further add up to SBI General’s digital proposition.” said Rajat Sharma, CRO of InsureMO.

About InsureMO

InsureMO is the connectivity and enablement platform for insurers, traditional channels, affinity partners, and FinTech/InsurTech startups. InsureMO (for “Insurance Middle Office”) is designed to accelerate insurance innovation, improve connectivity among stakeholders, and handle the massive volume, variation, and velocity of data in the “Digital Age.” InsureMO is a platform-as-a-service (PaaS) that acts as middleware for the insurance industry, freeing insurers from legacy constraints, and unlocking their ability to innovate and connect to stakeholders. InsureMO has a full set of insurance APIs and microservices for general (P&C), life, and health insurance businesses covering the entire policy life cycle. InsureMO supports Open API collaboration, is managed via Cloud Container (based on Docker and Kubernetes), and enables third parties to develop applications. Explore more about the InsureMO Insurance PaaS platform at https://insuremo.com/.

(Disclaimer: The above press release comes to you under an arrangement with PRNewswire India and this publication takes no editorial responsibility for the same)

Sanofi India appoints Preeti Futnani as General Manager, Vaccines

Sanofi India today announced the appointment of Preeti Futnani as the Company’s General Manager – Vaccines, with effect from June 1, 2022. She transitions from Sanofi’s Greater Gulf MCO (a cluster of six countries including Saudi Arabia, UAE, and Kuwait) where she was the Franchise Head for Dupixent Dermatology.

Futnani has over two decades of experience in delivering growth and transformation that spans several therapeutic areas and functions within healthcare (primary and specialty care, medical technology) and finance.

She started her journey with Sanofi over six years ago in Specialty Care Gulf, after various roles of increasing responsibility in Novartis marketing and commercial operations across Switzerland, UK, and India. She has held leadership roles in marketing, sales, and management across several geographies from mature markets in the UK and EU to emerging markets in Asia and the Middle East.

Futnani succeeds Annapurna Das, who is elevated to Head of Vaccines, Asia. Futnani will be based in Mumbai, India.

Annapurna Das

Head of Asia Vaccines

“We are delighted to have Preeti Futnani join us as the General Manager for Vaccines in India. Her global experience is an asset that will further sharpen Sanofi India’s focus of increasing vaccine coverage rates by driving the growth of our current portfolio and accelerating launch of innovative vaccines in the country. We wish her every success in this new role.”

 

Preeti Futnani

General Manager, Vaccines

“Vaccines is a priority growth driver for Sanofi. I am excited to join the team and lead the next phase of ambition for the business in India. Together, we are committed to safeguarding the Indian population from vaccine preventable diseases, at every stage of life, by leveraging the protective power of vaccination.”

Get Match Day Ready with flydubai

  • Match Day Shuttle flights between Dubai and Doha are available to book on flydubai’s website
  • Airline will offer up to 30 daily return flights from Dubai World Central (DWC) to Doha during the tournament

Dubai-based flydubai today announced that Match Day Shuttle flights between Dubai and Doha for the upcoming football tournament in Qatar are now available to book on its website. These Match Day Shuttle flights are offered in partnership with Qatar Airways and other partner GCC national carriers and will provide football fans with convenient travel options to the football matches that will take place from 21 November to 18 December 2022.

For the duration of the tournament, flydubai will offer up to 30 daily return flights between Dubai and Doha providing passengers with maximum convenience when selecting their flights. This service will allow match ticket holders to move freely from Dubai, soak up the atmosphere and enjoy a football match in Doha, and return to Dubai all on the same day.

Commenting on the announcement, Ghaith Al Ghaith, Chief Executive Officer (CEO) at flydubai, said: “we are pleased to partner with Qatar Airways and the other partner GCC national carriers to facilitate travel during the upcoming football tournament. By coming together, we are able to offer football fans from around the world the opportunity to experience the warm hospitality and rich culture of our region as they explore the sights and sounds of two countries. We are honoured to enter into this partnership which will enable more people to travel between Dubai and Qatar to share in their love for football as this sporting event comes to the Middle East and Arab World for the first time.”

Return Match Day Shuttle flights will be available from USD 258 in Economy Class and from USD 998 in Business Class. To ensure a seamless travel experience, these fares include a hand baggage allowance, a snack on board and complimentary ground transportation between the airport in Doha and the stadiums. With a high frequency of flights available each day, passengers are advised to select a flight that arrives in Doha at least four hours before the match kick-off time. In addition, passengers are advised to register for their Hayya card (Fan ID) in advance of their flight as this will be required for travel on all Match Day Shuttle flights and for entry to Qatar.

This dedicated and convenient service will operate from Dubai World Central (DWC) and will exclusively be available to match ticket holders. Match Day Shuttle flights must be booked as a separate itinerary and are not available for booking as part of a connecting itinerary. These flights will be operated by the airline’s fleet of Boeing 737 MAX aircraft offering passengers greater comfort on board.

For passengers who do not hold match day tickets, flydubai’s scheduled flights between Dubai International (DXB) and Hamad International Airport (DOH) will continue to operate during this period.

Further information about flydubai’s Match Day Shuttle flights is available here: https://www.flydubai.com/en/plan/match-day-shuttle-flights-to-doha

Information about the Hayya card is available here: https://hayya.qatar2022.qa/

Match Day Shuttle flights can be booked on the flydubai website: flydubai.com

IBSFINtech SaaS TMS, InTReaX is Powered by Oracle Cloud and is Now Available on Oracle Cloud Marketplace

IBSFINtech, the Enterprise TreasuryTech company, a leading provider of solutions for end-to-end digitization of Cash, Liquidity, Treasury, Risk, Trade Finance, and Supply Chain Finance functions of corporations and a member of Oracle PartnerNetwork (OPN), today announced that its SaaS Treasury Management Solution, InTReaX™ has achieved Powered by Oracle Cloud Expertise and is now available on Oracle Cloud Marketplace, offering added value to Oracle Cloud customers. The SaaS TMS InTReaX™ delivers the benefits of Oracle Cloud Infrastructure’s (OCI) deep and broad platform of public cloud service capabilities. OCI enables IBSFINtech to build and run a wide range of applications in a scalable, secure, highly available, and high-performance environment.

SaaS TMS InTReaX™ is a SaaS offering for Cash & Liquidity, Currency Risk, and Hedge Accounting, integrated with Refinitiv’s suite of risk and financial data solutions. The solution is hosted on one of the most secure, flexible, and scalable cloud infrastructure, OCI. The SaaS TMS enables the treasury teams to do more with less and facilitates critical decision-making with access to real-time and accurate information.

Oracle Cloud Marketplace is a one-stop shop for Oracle customers seeking trusted business applications offering unique business solutions, including ones that extend Oracle Cloud Applications. Oracle Cloud is an enterprise cloud that delivers massive, non-variable performance and next generation security across a comprehensive portfolio of services including SaaS, application development, application hosting, and business analytics. Customers get access to leading compute, storage, data management, security, integration, HPC, artificial intelligence (AI), and Blockchain services to augment and modernize their critical workloads. Oracle Cloud runs Oracle Autonomous Database, the industry’s first and only self-driving database.

“It has been our constant endeavor to offer future-ready solutions to our customers, and we do this with a thorough understanding of their changing needs. Treasury automation is a critical focus area for CXOs today. Having been mandated by boards, corporations globally are augmenting their corporate finance functions with robust treasury automation solutions. Our association with Oracle Cloud is a step forward in offering customers cloud-native solutions to support their business transformation journeys,” said CM Grover, MD & CEO, IBSFINtech India Pvt. Ltd. “IBSFINtech’s participation in Oracle PartnerNetwork with the Powered by Oracle Cloud Expertise further extends our commitment to the Oracle community and enables customers to easily reap the benefits of IBSFINtech SaaS TMS InTReaX™. We look forward to leveraging the power of Oracle Cloud to help us achieve our business goals.”

“The cloud represents a huge opportunity for our partner community,” said David Hicks, Vice-President, Worldwide ISV Cloud Business Development, Oracle. “IBSFINtech’s commitment to innovation with the Oracle Cloud and quality execution helps our mutual customers receive cloud-enabled Treasury Management solutions ready to meet critical business needs.”

Powered by Oracle Cloud Expertise recognizes OPN members with solutions that run on Oracle Cloud. For partners earning the Powered by Oracle Cloud Expertise, this achievement offers customers confidence that the partner’s application is supported by the Oracle Cloud Infrastructure SLA, enabling full access and control over their cloud infrastructure services as well as consistent performance.

View article…

(Disclaimer: The above press release comes to you under an arrangement with NewsVoir India and this publication takes no editorial responsibility for the same)

GODAWAN, THE ARTISANAL INDIAN SINGLE MALT, SPREADS ITS WINGS TO DUBAI

Diageo India launches Godawan, its artisanal single malt whisky, in international markets

BENGALURU, India, May 31, 2022 /PRNewswire/ — After the successful launch of Godawan in Jaipur, India, Diageo India is set to introduce Rajasthani tradition and culture to the world with the unveiling of this outstanding single malt across international markets.

Right after introducing the concept of Godawan’s purposeful luxury at the 75th Cannes Film Festival 2022, the ‘Spirit of the Desert’ now makes its way to another iconic desert destination – Dubai.

Godawan is crafted in, its provenance inspired by, and dedicated wholeheartedly to the Rajasthani ethos of ‘beauty in scarcity’, and sustainability. It pays homage to the spirit of its people who are known for their preservation and conservation skills, and for crafting exceptional things of brilliance from whatever little nature provides.

The heat of over 100°F combined with six-row barley, that requires lesser water, helps create a whisky with an incredible depth of flavour, and a rich and complex character. The aridity means the ‘Angel’s share’ is higher than average in Godawan – leaving behind a whisky with incredible depths of flavour, which is further enhanced by finishing in special casks selectively curated with Indian botanicals.

Godawan positions India as the haven of quality single malts on a global map and sets a new benchmark for sustainable and conscious Indian luxury with this launch in Dubai.

“We, at Diageo India, believe consumers, culture and community lie at the heart of our innovation. Godawan will help the world and our consumers discover an aspect of Indian culture hitherto unknown – rich and meaningful. This Single Malt is representative of what sustainable, mindful, purposeful modern Indian luxury looks like and Dubai is the right stage to take this story to the rest of the world. Godawan is not just rich in its story, but also in its distinct flavours. With this launch, I truly believe that Diageo India has set a new standard for single malts coming out of India,” says Hina Nagarajan, CEO, Diageo India.

Godawan is the embodiment of Diageo India’s commitment to the conservation of the Great Indian Bustard, its namesake. With only a few Great Indian Bustards left in the world, every bottle the company produces will contribute to the conservation of this exquisite bird. By bringing this unique story of Godawan to the deserts of Dubai, the aim is to set a new standard of accessible and purposeful luxury by offering crafted Indian spirits at an international scale.

About Diageo:

Diageo is a global leader in beverage alcohol with an outstanding collection of brands including Johnnie Walker, Crown Royal, J&B, Buchanan’s and Windsor whiskies, Smirnoff and Cîroc vodkas, Captain Morgan, Baileys, Don Julio, Tanqueray, and Guinness.

Diageo is listed on both the London Stock Exchange (DGE) and the New York Stock Exchange (DEO) and our products are sold in more than 180 countries around the world. For more information about Diageo, our people, our brands, and our performance, visit us at www.diageo.com. Visit Diageo’s global responsible drinking resource, www.DRINKiQ.com, for information, initiatives, and ways to share best practices.

Celebrating life, every day, everywhere.

Image: https://mma.prnewswire.com/media/1829332/Godawan_Artisnal_Single_Malt.jpg

(Disclaimer: The above press release comes to you under an arrangement with PRNewswire India and this publication takes no editorial responsibility for the same)

Springer Nature Opens its First Academic Research Lab in India at Manav Rachna Educational Institutions

Built on the tenets of innovation, science, research and technology the lab will be the source and hub of innovation, research and education, helping researchers create innovative ideas and equipping them with the skills needed to enter the workforce

Springer Nature has launched its first Academic Research Lab in India at Manav Rachna Educational Institutions, Faridabad.

Frank Vrancken Peeters, CEO, Springer Nature Group, is inaugurating the Springer Nature Academic Research Lab at Manav Rachna Educational Institutions at Faridabad, India

The Springer Nature Academic Research Lab will facilitate faculty research into new areas while offering students a unique opportunity to explore interdisciplinary studies that extend beyond the boundaries of traditional programmes or departments. The main focus areas of the lab will include scientific writing and publishing, and effective collaboration in research. It will provide opportunities for students to develop technical skills, build networks, incubate ideas, and showcase innovation. It will also provide the research community, faculty and students a chance to interact with renowned researchers in their domain of expertise, twice every month and discuss and learn about the technical discoveries.

Commenting, Frank Vrancken Peeters, Chief Executive of Springer Nature, said, “Science, technology and research are the backbone of a nation. We are delighted to establish this academic research lab at Manav Rachna Educational Institutions which will not only make content of our various journals accessible for students and faculty members, but will also be the centre for knowledge sharing and incubation of ideas. At Springer Nature, we believe in opening doors to discovery and knowledge, and the Springer Nature Academic Research Lab at Manav Rachna Educational Institutions will play an important role in helping us achieve this in India.”

Also speaking at the event, Venkatesh Sarvasiddhi, Managing Director, Springer Nature India Private Limited said, “India is a unique country with 15,000+ STEM colleges and 900+ Universities. However, only 30% of the total number of students in our country are employment ready when they pass out from these institutions. Our aim is to equip the bright young minds in our country with the latest information, research and technology which can propel their career and give them an edge in today’s fiercely competitive world. The Springer Nature Academic Research Lab at Manav Rachna will not only pave the way for better collaborations between the industry, academia and students, but will also foster a culture of innovation and research. We hope to replicate such labs with many other universities and institutes in the future.”

The leadership at Manav Rachna Educational Institutions feels that the academic research lab in their campus will provide the students and faculty an opportunity to discuss, collaborate and incubate ideas which will lead to enhanced quality of research in the future.

Dr. Amit Bhalla, Vice President, Manav Rachna Educational Institutions said, “Establishment of Springer Nature Academic Research Lab shall create an ecosystem of researchers of different age groups from all walks of life. This way, collaborative research and inter-disciplinary research opportunities will increase not just for Manav Rachna faculty and students but also for the researchers who wish to access the physical research facilities at the Springer Lab. This will also aid in building a community of researchers wherein they will get an opportunity to interact with the researchers from Springer. Access to the Springer Nature research database will also be provided to them.” He added, “Ideating, innovating and creating a new ecosystem is the main agenda of this lab that we aim to achieve with the expert guidance from research experts of Springer and Manav Rachna.”

The Lab was opened by Frank Vrancken Peeters, Chief Executive of Springer Nature in the presence of Martin Mos, Chief Operating Officer, Springer Nature; Daniel Korany, Chief Strategy Officer, Springer Nature, Venkatesh Sarvasiddhi, Managing Director, Springer Nature India, Matthias Wissel, CEO, Springer Nature Technology and Publishing Solutions, Dr. Amit Bhalla, Vice President, Manav Rachna Educational Institutions and other senior leadership of Manav Rachna.

View article…

(Disclaimer: The above press release comes to you under an arrangement with NewsVoir India and this publication takes no editorial responsibility for the same)

Launch of Edtech brand, ‘UtSide’ at EduSpark Summit, 2022

MUMBAI, India, May 30, 2022 /PRNewswire/ —  An initiative by Paperboat Studios, ‘UtSide’ is India’s 1st Online AVGC Campus, offering specialization courses in Creature FX, FX, Look Development, 3D Character Animation, VFX Compositing & Realtime 3D Cinematics, upskilling students and working professionals into becoming specialists, bridging the gap for both, quality content and quality professionals.

Soumitra Ranade, co-founder of Paperboat and Utside said, “We are very excited to team up with Puneet Sharma on this journey that will bring a paradigm shift in the AVGC sector. All the studios across India and in fact the world have multiple vacancies but very few trained personnel to fill those spots. UtSide will go a long way in addressing this very pressing issue.”

The early part of last decade witnessed a content consumption explosion across India with cheaper mobiles & affordable internet. During the pandemic, the consumption of content multiplied many folds, with an on- growing demand by consumers across different platforms.

The box office success of many Indian VFX blockbusters sequels such as Bahubali, KGF & RRR set a high benchmark for the AVGC industry. We are increasingly witnessing Indian VFX artists working in International Studios, contributing to Academy Award Winning movies bringing versatility and creativity to realms of life.

During this year’s Budget, Finance Minister Nirmala Sitharaman announced an AVGC promotion task force to help build domestic capacity and serve the global demand in the sector. The AVGC Promotion Task Force would help India achieve its potential of capturing 5 percent of the global $40 billion market share by 2025, with an annual growth of around 25-30 percent, and creating over 1,60,000 new jobs annually. It is also a prestigious moment for India to be ‘Country of Honor’ this year at the Cannes Film Festival.

Currently, there is an unprecedented demand for quality content in Animation & VFX which elevates the requirement for quality professionals in specialized departments such as Creature FX, Compositing, FX, Animation, Look Development, but there is dearth of quality artists requisite by studios worldwide.

Puneet Sharma, co-founder and Managing Director of Utside said, “We are catering to a huge demand for skilled specialists in Indian & International studios across the world. Our Specialisation programs delivered by seasoned working professionals on our online learning platform designed for AVGC Training is the need of the hour.”

UtSide, an Online AVGC Campus specially designed for AVGC training where seasoned mentors working in renowned studios groom creative artists into becoming specialists, to deliver impeccably – crafted visuals. UtSide, is in sync with the objectives of AVGC Promotion Task Force to upskill artistry into skilled professionals to serve the demands for our domestic and global industry engaging, educating and inspiring the next generation of animation and VFX artists.

For more information please visit:

WEBSITE: – www.utside.com

Logo: https://mma.prnewswire.com/media/1828543/Utside_Logo.jpg

(Disclaimer: The above press release comes to you under an arrangement with PRNewswire India and this publication takes no editorial responsibility for the same)

WBSETCL and Smile Train India Partner to Support Cleft Surgeries in West Bengal

230 cleft surgeries will be supported by WBSETCL at Smile Train Treatment centres in Kolkata

WBSETCL, a Govt. of West Bengal enterprise is one of the best transmission companies in India, announced their partnership with Smile Train, the world’s largest cleft focused NGO, to support 230 cleft surgeries in West Bengal as part of their CSR activities. The surgeries will be conducted at Smile Train’s treatment centres at Institute of Child Health and Repose Clinic & Research Centre Private Limited at Kolkata.

WBSETCL partners with Smile Train to support 230 cleft surgeries in West Bengal as part of their CSR activities in Kolkata

‘‘We have seen the impact and transformation in children once they receive cleft surgery. This partnership with Smile Train India will enable cleft affected children and their families from economically weaker sections of society to get access to high quality care. We look forward to creating many smiles and bringing transformation in many lives,” said Sri. Shamya Roy Choudhury, Director (HR&A), WBSETCL.

In India, more than 35,000 children are born with the facial birth difference of cleft lip and/or palate every year. It is estimated that hundreds of thousands of children with untreated clefts live in isolation, but more importantly, have difficulty eating, breathing, hearing and speaking, as their families cannot afford life-transforming cleft treatment. Smile Train’s sustainable model empowers local medical professionals with training, funding, and resources to provide free cleft surgery and comprehensive cleft care to children globally. Since the year 2000, Smile Train India has supported 650,000+ free cleft surgeries throughout the country, through a network of 150+ partner hospitals.

“At Smile Train, our endeavor is to not only support free, safe and quality cleft treatment, but also empower our local medical partners to provide comprehensive cleft care to children and enabling cleft affected children to live full and productive lives. For this, we rely on the support of our donors, and are thankful WBSETCL for their generous support. Together, we shall bring timely and comprehensive cleft care to children across West Bengal,” shared Mamta Carroll, Smile Train’s Senior Vice President and Regional Director for Asia.

Smile Train Partner surgeon Dr. Parthapratim Gupta, Smile Train Project Director at Institute of Child Health, Kolkata said, “Treatment for cleft lip and palate should not be delayed beyond a certain time as it leads to larger problems such as incorrect speech, orthodontic problems etc. With the support of Smile Train and WBSETCL, and with all safety protocols in place, we are providing safe and quality treatment to children born with cleft lip and palate to ensure they lead a healthy and productive life.”

Dr. Maneesh Sonthalia, Plastic Surgeon leading the Smile Train program at Repose Clinic & Research Centre, Kolkata said, ”There are many children with cleft lip & palate around the world who need help, but can’t receive timely care due to monetary constraints and lack of awareness and knowledge about this condition. The support from WBSETCL will help many children. Cleft is treatable and we are committed to help many more children across West Bengal.”

Smile Train has supported more than 25,000 free cleft surgeries in the state of West Bengal through a network of 6 partner hospitals at Kolkata, Bardhaman, Durgapur, Siliguri and Murshidabad where Smile Train supports cleft treatment throughout the year. To avail free cleft treatment, please call Toll Free Cleft Helpline – 1800 103 8301.

View article…

(Disclaimer: The above press release comes to you under an arrangement with NewsVoir India and this publication takes no editorial responsibility for the same)

Glenmark Pharma reports revenue growth of 5.6% YoY Q4; 12.4% for the full year FY 2021-22

MUMBAI, India, May 29, 2022 /PRNewswire/ —

Highlights for Q4 FY 2021–22

  • India Business grew by 7.4% YoY to Rs. 8,847 Mn.
  • Europe Business grew by 17.6% YoY to Rs. 4,968 Mn.
  • ROW Business grew by 18.1% YoY to Rs. 5,479 Mn.
  • US Business recorded de-growth of (7.9%) YoY to Rs. 7,378 Mn.
  • Net Debt reduction of Rs. 1,290 Mn in FY22.

Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven global pharmaceutical company, today announced its financial results for the fourth quarter ended March 31, 2022.

For the Fourth Quarter of FY 2021–22, Glenmark’s consolidated revenue was at Rs. 30,191 Mn as against Rs. 28,599 Mn recording an increase of 5.6 % YoY.

Adjusted EBITDA[i] was Rs. 5,022 Mn in the quarter ended March 31, 2022, with margins of 16.6 %.

Reported EBITDA was Rs. 4,634 Mn in the quarter ended March 31, 2022, as compared to Rs. 5,234 Mn in the previous corresponding quarter with margins of 15.3%.

Adjusted Net Profit (PAT)[ii] was at Rs. 2,939 Mn for the quarter ended March 31, 2022.

Reported PAT was at Rs. 1,726 Mn for the quarter ended March 31, 2022, as compared to Rs. 2,340 Mn in the previous corresponding quarter.

For the year ended March 31, 2022, Glenmark’s consolidated revenue was at Rs. 1,23,049 Mn as against Rs. 1,09,439 Mn, recording an increase of 12.4 % over the previous corresponding period.

Adjusted EBITDA[iii] for the fiscal year ended March 31, 2022, stood at Rs. 23,591 Mn.

Reported EBITDA for the fiscal year ended March 31, 2022 stood at Rs. 23,203 as against Rs. 20,844 Mn in the previous corresponding period. Net Profit (PAT) was at Rs. 9,936 Mn. for the year ended March 31, 2022, as against Rs. 9,701 Mn. in the previous year. Earnings Per Share (EPS) is at Rs. 33.4 as compared to Rs. 34.4 YoY basis.

“We delivered consistent performance throughout the year and achieved our key objectives, despite challenging global macro environment. We were able to successfully list Glenmark Lifesciences on the Indian Bourses. The out-licensing deal for ISB 880 with Almirall and US FDA approval for Ryaltris™, further established us as the leading innovation-driven pharma company in the country.” said Glenn Saldanha, Chairman and Managing Director, Glenmark Pharmaceuticals. He added,”We are confident of growing our business with continuous emphasis on innovation, sustainability, and prioritizing free cash generation for additional debt reduction.”

1.  GLENMARK PHARMACEUTICALS LTD. 

India

Sales from the formulation business in India for the Fourth Quarter of FY 2021-22 was at Rs. 8,847 Mn as against Rs. 8,238 Mn in the previous corresponding quarter, recording growth of 7.4% YoY. The India business contribution was at 29% of the total revenues in Q4 FY 2021-22 similar to Q4 FY 2020-21.

Glenmark Consumer Care Business

GCC business recorded revenue of Rs. 619 Mn in the fourth quarter and Rs 1,790 Mn in FY22 with secondary sales growth of 23.4% in Q4 and 12.6% YoY in FY22 respectively. This growth was led by new product launches, especially Candid Cream where secondary sales grew 30% YoY annually while La Shield recorded secondary sales growth of 95% YoY.

North America

North America registered revenue from the sale of finished dosage formulations of Rs. 7,378 Mn for the quarter ended March 31, 2022 as against revenue of Rs. 8,012 Mn for the previous corresponding quarter, recording de-growth of (7.9)% YoY and (2.5)% QoQ. North America business contributed 24% of the total revenues in Q4 FY 2021-22 as compared to 28% in Q4 FY 2020-21.

Asia, MEA, LATAM and RCIS Region (ROW)

For the fourth quarter of FY 2021-22, revenue from RoW was Rs. 5,479 Mn as against Rs. 4,641 Mn for the previous corresponding quarter, recording growth of 18.1% YoY. ROW business contributed 18% of the total revenues in Q4 FY 2021-22 as compared to 16% in Q4 FY 2020-21.

Europe

Glenmark Europe’s operations revenue for the fourth quarter of FY 2021-22 was at Rs. 4,968 Mn as against Rs. 4,223 Mn recording growth of 17.6 % YoY and 30.5% QoQ. Europe business contributed 16% of the total revenues in Q4 FY 2021-22 as compared to 15% in Q4 FY 2020-21.

Glenmark Lifesciences (GLS)

Revenues from operations including captive sales were Rs. 5,140.6 Mn as against Rs. 4,671.6 Mn, growing at 10% YoY for Q4 FY22 and Rs. 21,232.1 Mn for FY 22, a growth of 12.6%. During FY22, revenues from the regulated markets witnessed a healthy growth of 21.4% YoY, whereas revenues from the emerging markets declined by 6.3% YoY due to high base of COVID products sales last year. EBITDA was at Rs. 1,473.1 Mn for Q4FY22 with margin at 28.7% and ₹ 6,307.6 Mn for FY22 with margin at 29.7%.

External sales for Glenmark Life Sciences were at Rs. 3,283 Mn as against Rs. 3,311 Mn in Q4 FY21, recording decline of (0.9) % YoY and 8.3% growth QoQ.

2.  ICHNOS Sciences

Glenmark has invested Rs. 1,640 Mn in the fourth quarter of the financial year as compared to Rs. 1,880 Mn in Q4 FY 2020-21. Thus, for the entire financial year, Glenmark invested Rs. 6,627 Mn as compared to Rs. 7,570 Mn.

For further updates on the pipeline and the organization, please log on to www.ichnossciences.com. The pipeline update for the fourth quarter is published on this site.

About Glenmark Pharmaceuticals Ltd

Glenmark Pharmaceuticals Ltd. (BSE: 532296 | NSE: GLENMARK) is an innovation-driven global pharmaceutical company with a presence across Specialty, Generics and OTC businesses. It focuses on the key therapeutic areas of respiratory, dermatology and oncology. The company has 10 world-class manufacturing facilities spread across 4 continents and operations in over 80 countries. Glenmark is ranked among the world’s top 100 biopharmaceutical companies (Top 100 Companies Ranked by Pharmaceutical Sales, 2020, by In Vivo/Scrip 100) and among the world’s top 50 companies in the off-patent sector (Top 50 Generics and Biosimilars Companies ranked by Sales, 2020, by Generics Bulletin/In Vivo). The company was listed on the Dow Jones Sustainability Index (DJSI), one of the world’s most respected and widely accepted sustainability benchmarks, under the category of emerging markets (2021) for the fourth consecutive year in a row. For more information, visit www.glenmarkpharma.com.

References

  1. Adjusted for one time COVID related inventory provision of Rs.388 Mn in Q4 FY22.
  2. Adjusted for one time CoVid related inventory provision and exceptional items related to recall and associated remediation cost in the US.
  3. Adjusted for one time CoVid related inventory provision of Rs.388 Mn in Q4 FY22.
  4. (Disclaimer: The above press release comes to you under an arrangement with PRNewswire India and this publication takes no editorial responsibility for the same)